Wells Fargo & Company Spero Therapeutics, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 200 shares of SPRO stock, worth $206. This represents 0.0% of its overall portfolio holdings.

Number of Shares

200

Previous 1,000 80.0%

Holding current value

$206

Previous $1,000 100.0%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$1.19 - $1.5 $952 - $1,200	-800 Reduced 80.0%	200 $0
Q2 2024 Aug 13, 2024	BUY	$1.27 - $1.8 $584 - $828	460 Added 85.19%	1,000 $1,000
Q1 2024 May 10, 2024	BUY	$1.35 - $1.79 $9 - $12	7 Added 1.31%	540 $0
Q4 2023 Feb 09, 2024	BUY	$1.0 - $1.47 $18 - $26	18 Added 3.5%	533 $0
Q3 2023 Nov 13, 2023	SELL	$1.2 - $1.63 $16 - $22	-14 Reduced 2.65%	515 $0
Q2 2023 Aug 15, 2023	BUY	$1.42 - $1.95 $25 - $35	18 Added 3.52%	529 $0
Q1 2023 May 12, 2023	BUY	$1.35 - $2.0 $139 - $206	103 Added 25.25%	511 $0
Q4 2022 Feb 13, 2023	BUY	$1.55 - $2.12 $7 - $10	5 Added 1.24%	408 $0
Q3 2022 Nov 14, 2022	SELL	$0.68 - $2.2 $331 - $1,073	-488 Reduced 54.77%	403 $0
Q2 2022 Aug 12, 2022	SELL	$0.74 - $7.44 $9,910 - $99,636	-13,392 Reduced 93.76%	891 $1,000
Q1 2022 May 16, 2022	SELL	$7.87 - $15.15 $66,194 - $127,426	-8,411 Reduced 37.06%	14,283 $124,000
Q4 2021 Feb 14, 2022	BUY	$13.09 - $18.77 $195,407 - $280,198	14,928 Added 192.22%	22,694 $363,000
Q3 2021 Nov 15, 2021	SELL	$13.03 - $19.51 $418,015 - $625,900	-32,081 Reduced 80.51%	7,766 $144,000
Q2 2021 Aug 16, 2021	BUY	$12.22 - $15.79 $267,947 - $346,227	21,927 Added 122.36%	39,847 $556,000
Q1 2021 May 13, 2021	SELL	$13.23 - $21.48 $315,919 - $512,920	-23,879 Reduced 57.13%	17,920 $265,000
Q4 2020 Feb 09, 2021	BUY	$11.65 - $22.07 $98,139 - $185,917	8,424 Added 25.24%	41,799 $811,000
Q3 2020 Nov 05, 2020	SELL	$8.96 - $14.12 $34,146 - $53,811	-3,811 Reduced 10.25%	33,375 $373,000
Q2 2020 Aug 13, 2020	BUY	$7.27 - $14.18 $75,535 - $147,330	10,390 Added 38.77%	37,186 $503,000
Q1 2020 May 14, 2020	BUY	$5.27 - $10.41 $141,214 - $278,946	26,796 New	26,796 $217,000

Others Institutions Holding SPRO

# of Institutions

Shares Held

13.9M

Call Options Held

200

Put Options Held

200

View Full List

About Spero Therapeutics, Inc.

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $36.1M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

More about SPRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Spero Therapeutics, Inc. Transaction History